<DOC>
	<DOC>NCT02046382</DOC>
	<brief_summary>This study is being done to evaluate the scheduled use of intravenous (IV) acetaminophen among cesarean section patients. The study hopes to find out if patients who receive scheduled IV acetaminophen for 48 hours following delivery have lower self-reported pain scores and use less narcotic pain medication than patients who do not receive IV acetaminophen.</brief_summary>
	<brief_title>RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Cesarean Pain Relief</brief_title>
	<detailed_description>See Brief Summary</detailed_description>
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Age greater than or equal to 18 years Scheduled cesarean section delivery Patient of TriHealth's Faculty Medical Center or TriState Maternal Fetal Medicine Associates Singleton pregnancy Term delivery (greater than or equal to 37 weeks) Spinal/epidural anesthesia with epidural analgesia (duramorph) Use of pfannenstiel incision Weight less than 50 kg Allergy to study drugs (acetaminophen, oxycodone, duramorph, NSAIDS) Multiple gestation pregnancy Cesarean section for preterm delivery (less than 37 weeks) Fetal anomalies Inability to use epidural duramorph at time of procedure General anesthesia used Vertical skin incision Opioid addiction Liver dysfunction (hepatitis, HELLP (hemolysis, elevated liver enzymes, and low platelet count), preeclampsia)</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>IV Acetaminophen</keyword>
	<keyword>Cesarean Section</keyword>
	<keyword>Pain, Postoperative</keyword>
</DOC>